214 related articles for article (PubMed ID: 24706389)
21. Determinants of hospital costs in community-acquired pneumonia.
Reyes S; Martinez R; Vallés JM; Cases E; Menendez R
Eur Respir J; 2008 May; 31(5):1061-7. PubMed ID: 18448502
[TBL] [Abstract][Full Text] [Related]
22. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
Weycker D; Richardson E; Oster G
Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
[TBL] [Abstract][Full Text] [Related]
23. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
[No Abstract] [Full Text] [Related]
24. Resource utilization and costs of treating severe rotavirus diarrhea in young Mexican children from the health care provider perspective.
Granados-García V; Velázquez-Castillo R; Garduño-Espinosa J; Torres-López J; Muñoz-Hernández O
Rev Invest Clin; 2009; 61(1):18-25. PubMed ID: 19507471
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceutical industry research and cost savings in community-acquired pneumonia.
Kessler LA; Waterer GW; Barca R; Wunderink RG
Am J Manag Care; 2002 Sep; 8(9):798-800. PubMed ID: 12234020
[TBL] [Abstract][Full Text] [Related]
26. Economic cost of community-acquired pneumonia in New Zealand adults.
Scott G; Scott H; Turley M; Baker M
N Z Med J; 2004 Jun; 117(1196):U933. PubMed ID: 15280937
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
[TBL] [Abstract][Full Text] [Related]
28. Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.
Schmedt N; Heuer OD; Häckl D; Sato R; Theilacker C
BMC Health Serv Res; 2019 Jan; 19(1):30. PubMed ID: 30642312
[TBL] [Abstract][Full Text] [Related]
29. Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP.
Mangen MJ; Bonten MJ; de Wit GA
BMC Infect Dis; 2013 Dec; 13():597. PubMed ID: 24354588
[TBL] [Abstract][Full Text] [Related]
30. Treatment costs of community-acquired pneumonia in an employed population.
Colice GL; Morley MA; Asche C; Birnbaum HG
Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
[TBL] [Abstract][Full Text] [Related]
31. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
[TBL] [Abstract][Full Text] [Related]
32. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
33. The cost of treating community-acquired pneumonia.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1998; 20(4):820-37. PubMed ID: 9737840
[TBL] [Abstract][Full Text] [Related]
34. The cost of outpatient pneumonia in children <5 years of age in Fiji.
Temple B; Griffiths UK; Mulholland EK; Ratu FT; Tikoduadua L; Russell FM
Trop Med Int Health; 2012 Feb; 17(2):197-203. PubMed ID: 22008519
[TBL] [Abstract][Full Text] [Related]
35. A population-based study of the costs of care for community-acquired pneumonia.
Bartolomé M; Almirall J; Morera J; Pera G; Ortún V; Bassa J; Bolíbar I; Balanzó X; Verdaguer A;
Eur Respir J; 2004 Apr; 23(4):610-6. PubMed ID: 15083763
[TBL] [Abstract][Full Text] [Related]
36. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003.
Filia A; Brenna A; Panà A; Cavallaro GM; Massari M; Ciofi degli Atti ML
BMC Public Health; 2007 Jul; 7():169. PubMed ID: 17650298
[TBL] [Abstract][Full Text] [Related]
37. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
Goss CH; Rubenfeld GD; Park DR; Sherbin VL; Goodman MS; Root RK
Chest; 2003 Dec; 124(6):2148-55. PubMed ID: 14665494
[TBL] [Abstract][Full Text] [Related]
38. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
Cortoos PJ; Gilissen C; Laekeman G; Peetermans WE; Leenaers H; Vandorpe L; Simoens S
Scand J Infect Dis; 2013 Mar; 45(3):219-26. PubMed ID: 23113827
[TBL] [Abstract][Full Text] [Related]
39. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
Sato R; Gomez Rey G; Nelson S; Pinsky B
Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
[TBL] [Abstract][Full Text] [Related]
40. Resource utilization and direct costs of pediatric HIV in Italy.
Giacomet V; Fabiano V; Lo Muto R; Caiazzo MA; Curto A; Rampon O; Zuccotti GV; Garattini L
AIDS Care; 2013; 25(11):1392-8. PubMed ID: 23414422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
